The first patient with relapsed or refractory CD5-positive T-cell lymphoma has been dosed with the CAR-T cell therapy MB-105.

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

Dr. Matthew Galsky discusses the FDA approval of Imfinzi and chemo before and after surgery for muscle-invasive bladder ...

An expert sat down to discuss the emotional and physical barriers patients may face when seeking support for fear of cancer ...

It’s spring, a time for new beginnings following a cancer diagnosis; however, I have an ongoing issue that I can’t dismiss.

The Oncodetect test detects molecular residual disease across solid tumors using circulating tumor DNA to inform recurrence ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.